iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF
2B70ETFF
€7.50 ▲ +0.77%
Jun 12, 2026
2
iShares IV Public Limited Company - iShares NASDAQ US Biotechnology UCITS ETF
€7.50 ▲ +0.77%
Jun 12, 2026
2B70ETFF

About the company

The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.

Arberion
Loading market data